Medical economics

Financial risks posed by unproven stem cell interventions in Japan

The research group led by Professor Misao Fujita conducted a study to estimate the total amount the Japanese government would refund if a patient received unproven cell interventions and applied for a medical expense deduction.

page 1 from 40